Showing results (1-10 of 220) with videos related to
Sort By:
Pageof 22
Trends in Cancer|September 6, 2024
CD4+ T cells in antitumor immunityElena Montauti, David Y Oh, Lawrence FongImmunity|December 15, 2021
Cytotoxic CD4+ T cells in cancer: Expanding the immune effector toolboxDavid Y Oh, Lawrence FongJournal of the National Comprehensive Cancer Network : JNCCN|August 19, 2015
On the Verge: Immunotherapy for Colorectal CarcinomaDavid Y Oh, Alan P Venook, Lawrence FongAdvances in Experimental Medicine and Biology|February 1, 2021
Regulation of Treg Functions by the Ubiquitin PathwayElena Montauti, Deyu FangOncoimmunology|December 15, 2018
Neoadjuvant sipuleucel-T induces both Th1 activation and immune regulation in localized prostate cancerKatsunobu Hagihara, Stephen Chan, Li Zhang, et al.Journal for Immunotherapy of Cancer|May 8, 2020
Combination immunotherapy induces distinct T-cell repertoire responses when administered to patients with different malignanciesJason Cham, Li Zhang, Serena Kwek, et al.Cancer Research|December 30, 2016
Immune Toxicities Elicted by CTLA-4 Blockade in Cancer Patients Are Associated with Early Diversification of the T-cell RepertoireDavid Y Oh, Jason Cham, Li Zhang, et al.Cancer Immunology Research|September 24, 2020
Long-term Sculpting of the B-cell Repertoire following Cancer Immunotherapy in Patients Treated with Sipuleucel-TLi Zhang, Harini Kandadi, Hai Yang, et al.Cancer Immunology, Immunotherapy : CII|January 9, 2021
Early changes in the circulating T cells are associated with clinical outcomes after PD-L1 blockade by durvalumab in advanced NSCLC patientsElliot Naidus, Jerome Bouquet, David Y Oh, et al.Pageof 22